Viewing Study NCT03865095


Ignite Creation Date: 2025-12-24 @ 1:57 PM
Ignite Modification Date: 2026-01-03 @ 8:39 PM
Study NCT ID: NCT03865095
Status: COMPLETED
Last Update Posted: 2021-03-03
First Post: 2019-03-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Muscle Mass Loss in Critically Ill Patients.
Sponsor: Masaryk University
Organization:

Study Overview

Official Title: Muscle Mass Loss in Critically Ill and Its Risk Factors. A Prospective Observational Study.
Status: COMPLETED
Status Verified Date: 2021-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: MUSIC
Brief Summary: The purpose of the study is to describe the change in muscle mass in critically ill patients. The study will examine rectus femoris cross sectional area with ultrasound and identify risk factors of this changes.
Detailed Description: The study will commence following the Approval by The Ethics Research Committee. All patients admitted to our ICU from the 1st of March 2019 to the 31st of August 2019 will be enrolled after fulfilling the inclusion criteria and in the absence of any exclusion criteria. Informed consent will be requested. Ultrasound measurement of rectus femoris cross sectional area will be performed in first 24 hours after admission to ICU.

Study data will be entered in study form. The ultrasound measurement will be repeated on day 7 of hospitalisation.

Changes in rectus femoris cross sectional area and potential risk factors will be analysed. The length of ICU length of stay and 28-day mortality will be also monitored.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: